A clearly positioned tretinoin product with a visible supply period. The ingredient category is its strongest comparison point; the prominent patient-improvement percentages require more context than the headline provides.
- Key formulation
- Tretinoin-based compounded cream
- Product type
- Prescription compounded topical
- Price checked October 8, 2026
- $35/month equivalent; two-month supply
- Medical review
- No independent medical review claimed
What stands out
- Tretinoin is clearly identified
- Two-month supply is stated
What to weigh
- The monthly headline is not necessarily a monthly charge
- Provider-reported outcomes are not comparative efficacy evidence
What is in the formula?
Musely describes this prescription cream as a tretinoin treatment for visible lines, tone and pores. Its current listing advertises a two-month supply. The exact prescribed strength matters more than a broad claim that a product is prescription strength.[source]
How strong is the evidence?
Retinoid guidance supports discussing tretinoin for some visible signs of skin aging. That background should be distinguished from Musely’s self-reported patient outcomes. A survey percentage does not establish the size of improvement, a control comparison or the effect of this cream relative to another tretinoin formulation.[source]
Compounded drugs are not reviewed by FDA for safety, effectiveness or quality before they are marketed. That does not mean every compounded prescription is inappropriate; it means the consultation and pharmacy information matter, and approved-product evidence should not be silently transferred to this formula.[source]
What it means for your routine
The consultation should establish how the cream fits your existing routine and whether your skin is likely to tolerate it. Starting several new actives simultaneously makes side effects harder to interpret. Ask what progress and tolerability should look like at the next review rather than judging treatment by how much it peels.
Questions to raise with your prescriber
The AAD cautions that retinoids can be unsuitable for people with dryness, certain inflammatory conditions or pregnancy. Share those considerations with the prescriber. Persistent irritation should prompt a clinical discussion rather than simply increasing moisturizer and continuing without advice.
What to check in the price
The posted $35 monthly equivalent for a two-month supply implies $70 in product cost for that period. It does not establish whether a separate doctor visit, tax or future renewal change applies. Record the actual checkout total before comparing it with a single-month plan.[source]
How to compare the alternatives
CoreAge Rx Smooth Move and Curology HydroTret are useful comparisons. Look at ingredient combinations, actual concentration, base, prescription adjustments and full cost. There is no verified basis in this review to assign any of them a universal efficacy score.
See the full brand review for the care model, and compare the other product reviews before making a treatment decision.
Your questions, answered
Is this an FDA-approved finished product?
This review covers a compounded prescription formula. FDA does not approve compounded drugs as finished products. Ask the prescriber to explain why the specific preparation is appropriate.
Did you test the cream?
No. This is an analysis of current provider information and cited clinical or regulatory guidance. We did not buy, apply or laboratory-test the product.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- Musely — The Anti-Aging CreamProduct page; price expressed as a monthly equivalent for a two-month supply
- American Academy of Dermatology — Retinoid or retinol?Dermatology guidance on retinoids, irritation and pregnancy
- FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations